Drax Exametazime

Drax Exametazime is a radioactive (nuclear) medication used for a procedure called leukocyte-labeled scintigraphy. This is a procedure that can help providers scan and find the source of stomach infections and inflammatory bowel disease. Drax Exametazime is injected intravenously (IV or into the vein), and will travel throughout the body. After the first hour, this medication can be seen in your stomach. Your provider will determine if you have a stomach infection or inflammatory bowel disease depending on if the medication builds up or not within 4 hours.

The most common side effects of Drax Exametazime include rash, redness, face swelling, and fever. Other side effects can include tiredness, feeling unwell, headache, dizziness, weakness, flushing, nausea, and vomiting. Although rare, Drax Exametazime might cause an allergic reaction, including anaphylaxis. Let your provider know right away if you experience any signs and symptoms of an allergic reaction, such as hives, swelling of the tongue, mouth, or throat, or difficulty breathing.

Long-term exposure to radiation can raise the risk of cancer. Your provider will handle and prepare Drax Exametazime safely to limit your exposure. To avoid getting radioactive medication exposure in your kidneys and bladder for a long time, make sure to drink a lot of fluids and urinate often after you receive Drax Exametazime. This can help your body flush out the medication quicker.

Once Drax Exametazime is given to you, your provider will start getting your stomach scans 30 minutes to 1 hour after the injection, and will continue up to 4 hours.